SAMSARA BIOCAPITAL, LLC
PALO ALTO, CA · CIK 1744967 · 13F filing filed 2022-08-15
SEC-registered investment adviser since 2018 · limited liability company
- Assets managed$2.2bn
- Staff31 · 22 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 · $2.3bn gross assets
- Websitesamsaracap.com
- Form ADV · 2026-06-26SEC adviser record
- Kindventure
- Others nearbyPalo Alto, CA
As an employer
- Private fundsventure capital 3
US visa salary filings
- Filings FY20242
- Median salary offered$187,500
- Middle half$181,250 – $193,750
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Senior AssociatePalo Alto, CA | 2 | $187,500 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.
$373.9m
reported value
-5.4% vs Q1 2022
56positions
64.8%in top 10
5 new
7 added
14 reduced
5 sold out
vs Q1 2022
Options: 1 call positions ($1.2m notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CHINOOK THERAPEUTICS INC ADRO | $90.3m24.14% | Added +570.0k |
| NKARTA INC NKTX | $35.3m9.45% | Added +833.3k |
| SCHOLAR ROCK HLDG CORP SRRK | $25.2m6.75% | Added +4.3m |
| GRAPHITE BIO INC GRPH | $23.3m6.22% | Added +386.7k |
| ARCELLX INC ACLX | $19.2m5.14% | Added +64.1k |
| FORMA THERAPEUTICS HLDGS INC SHS | $10.8m2.88% | Unchanged |
| LYRA THERAPEUTICS INC LYRA | $10.0m2.69% | New |
| ACLARIS THERAPEUTICS INC ACRS | $9.7m2.60% | Reduced -98.0k |
| IVERIC BIO INC OPHT | $9.7m2.60% | Reduced -252.5k |
| INTERCEPT PHARMACEUTICALS IN ICPT | $8.8m2.37% | Unchanged |
| SUTRO BIOPHARMA INC COM | $8.7m2.33% | Unchanged |
| RAIN ONCOLOGY INC COM | $8.7m2.32% | Reduced -10.7k |
| HILLEVAX INC COM | $8.3m2.23% | New |
| INSTIL BIO INC COM | $8.3m2.21% | Reduced -203.7k |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $8.2m2.21% | Reduced -190.4k |
| PEPGEN INC PEPG | $6.5m1.73% | New |
| IMMUNOCORE HLDGS PLC IMCR | $6.0m1.61% | Unchanged |
| ZYMEWORKS INC ZYME | $5.1m1.38% | Unchanged |
| JIYA ACQUISITION CORP COM CL A | $5.0m1.34% | Unchanged |
| IO BIOTECH INC IOBTQ | $4.7m1.26% | Reduced -112.0k |
| VERONA PHARMA PLC VRNA | $4.7m1.25% | Unchanged |
| JANUX THERAPEUTICS INC JANX | $4.4m1.18% | Reduced -51.5k |
| DICE THERAPEUTICS INC COM | $3.9m1.05% | Added +25.0k |
| EYEPOINT PHARMACEUTICALS INC EYPT | $3.8m1.01% | Unchanged |
| DAY ONE BIOPHARMACEUTICALS I COM | $3.5m0.94% | Reduced -6.1k |
| DECIBEL THERAPEUTICS INC COM | $3.4m0.90% | Reduced -24.8k |
| BCLS ACQUISITION CORP COM CL A | $3.0m0.79% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $2.9m0.76% | Unchanged |
| IGM BIOSCIENCES INC IGMS | $2.8m0.75% | Unchanged |
| VIRACTA THERAPEUTICS INC SNSS | $2.7m0.72% | Reduced -21.3k |
| RECURSION PHARMACEUTICALS IN RXRX | $2.2m0.58% | Reduced -271.2k |
| BOLT BIOTHERAPEUTICS INC COM | $2.1m0.57% | Unchanged |
| AMRYT PHARMA PLC SPONSORED ADS | $2.1m0.57% | Added +25.0k |
| ALX ONCOLOGY HLDGS INC ALXO | $2.1m0.57% | Unchanged |
| ALBIREO PHARMA INC BIOD | $2.0m0.53% | Unchanged |
| SYROS PHARMACEUTICALS INC SYRS | $1.8m0.49% | Unchanged |
| SCIENCE 37 HOLDINGS INC COM | $1.8m0.48% | Unchanged |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $1.6m0.43% | Unchanged |
| RHYTHM PHARMACEUTICALS INC RYTM | $1.4m0.38% | Unchanged |
| EQUILLIUM INC EQ | $1.3m0.34% | Unchanged |
| VTV THERAPEUTICS INC VTVT | $1.2m0.33% | Unchanged |
| ELEVATION ONCOLOGY INC COM | $1.2m0.31% | Reduced -101.7k |
| NOVAVAX INC NVAX | $1.1m0.29% | Reduced -5.9k |
| SURROZEN INC COM | $900.0k0.24% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $717.0k0.19% | Unchanged |
| ATRECA INC BCEL | $710.0k0.19% | Unchanged |
| SPRINGWORKS THERAPEUTICS INC SWTX | $547.0k0.15% | Reduced -37.0k |
| ALLAKOS INC ALLKG | $539.0k0.14% | Unchanged |
| AEGLEA BIOTHERAPEUTICS INC AGLE | $446.0k0.12% | Unchanged |
| ALLOVIR INC COM | $321.0k0.09% | Unchanged |
| KRONOS BIO INC KRON | $284.0k0.08% | Unchanged |
| KALA PHARMACEUTICALS INC COM | $180.0k0.05% | Unchanged |
| NGM BIOPHARMACEUTICALS INC NGM | $175.0k0.05% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $75.0k0.02% | Unchanged |
| NUVATION BIO INC NUVB.WS | $37.0k0.01% | New |
| SURROZEN INC *W EXP 08/01/203 | $19.0k0.01% | New |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| ODONATE THERAPEUTICS INC | $925.0k700.4k shares |
| BIONTECH SE BNTX | $688.0k4.0k shares |
| ROCKET PHARMACEUTICALS INC RCKT | $643.0k40.5k shares |
| VISTAGEN THERAPEUTICS INC VTGN | $606.0k488.6k shares |
| AMARIN CORP PLC | $82.0k25.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| NOVAVAX INC NVAX · Call | $1.2m23.4k shares | Unchanged |